Epstein–Barr virus (EBV) is a ubiquitous human lymphotropic herpesvirus with a well-
established causal role in several cancers. Recent studies have provided compelling …

Epstein–Barr virus (EBV) infection precedes multiple sclerosis (MS) pathology and cross-
reactive antibodies might link EBV infection to CNS autoimmunity. As an altered anti-EBV T …

Immediately after entry into host cells, viruses are sensed by the innate immune system,
leading to the activation of innate antiviral effector mechanisms including the type I interferon …

Epstein–Barr virus (EBV) infection is extremely common worldwide, with approximately 90%
of adults testing positive for EBV antibodies. Human are susceptible to EBV infection, and …

Head and neck cancer (HNC) is the sixth most common cancer type, accounting for
approximately 277,597 deaths worldwide. Recently, the Food and Drug Administration …

Kaposi sarcoma associated herpesvirus (KSHV) is associated with around 1% of all human
tumors, including the B cell malignancy primary effusion lymphoma (PEL), in which co …

Coronavirus disease 2019 (COVID-19) has been a pandemic for the past two years.
Predicting patient prognosis is critical. Although immune checkpoints (ICs) were shown to be …

The Epstein Barr virus (EBV) is one of the prominent human tumor viruses, and it is
efficiently immune-controlled in most virus carriers. Cytotoxic lymphocytes strongly expand …

Following infection of B cells, Epstein Barr virus (EBV) engages host pathways that mediate
cell proliferation and transformation, contributing to the propensity of the virus to drive …

There are currently no accurate biomarkers for optimal treatment selection in early-stage
non-small cell lung cancer (NSCLC). Novel therapeutic targets are needed to improve …